Evaluating the Role of echocardiography (EchoCG) and Cardiospecific Enzymes in Diagnosing Heart Dysfunction in Military Patients

This study evaluates the role of echocardiography (EchoCG) and cardiospecific enzymes in diagnosing heart dysfunction in military patients, particularly those experiencing intra-abdominal hypertension (IAH) due to trauma or surgical interventions. IAH is known to significantly impact cardiovascular function, but early detection of myocardial dysfunction is crucial for improving patient outcomes. The study included military personnel who had sustained abdominal trauma or undergone abdominal surgeries between 2015 and 2020. Cardiovascular assessments were performed using EchoCG to measure myocardial contractility, cardiac output, and other hemodynamic parameters. Additionally, cardiospecific enzymes, such as troponin and creatine kinase-MB (CK-MB), were measured to identify myocardial injury. Results indicated that EchoCG provided valuable insights into early signs of heart dysfunction, including reduced myocardial contractility and abnormal hemodynamic responses. Elevated levels of troponin and CK-MB were found to correlate with impaired myocardial function, particularly in patients with elevated IAP. The combination of EchoCG and enzyme measurements allowed for a more comprehensive assessment of heart function and facilitated early intervention. These findings suggest that EchoCG and cardiospecific enzymes are effective diagnostic tools for detecting heart dysfunction in military patients, enabling timely therapeutic strategies and improving overall patient outcomes in critical care settings. The study emphasizes the importance of incorporating these diagnostic methods into routine practice to enhance cardiovascular monitoring and treatment in military healthcare.